Dysregulation of Zinc Finger Protein 395 Contributes to the Pathogenesis of Chondrosarcoma

Upregulation of miR-211 Promotes Chondrosarcoma Development via Targeting Tumor Suppressor VHL

(2020) Changbao Chen et al.   OncoTargets and Therapy

HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395

(2020) Guoliang Sun et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

PRMT1 potentiates chondrosarcoma development through activation of YAP activity

(2019) Changbao Chen et al.   MOLECULAR CARCINOGENESIS

Adenoviral delivery of VHL suppresses bone sarcoma cell growth through inhibition of Wnt/β-catenin signaling

(2018) Changbao Chen et al.   CANCER GENE THERAPY

Chondrosarcoma: An overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets

(2018) Elahe Nazeri et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Novel therapeutic approaches in chondrosarcoma

(2017) Genovefa Polychronidou et al.   Future Oncology

ZNF395 Is an Activator of a Subset of IFN-Stimulated Genes

(2017) Linda Schroeder et al.   MEDIATORS OF INFLAMMATION

VHL Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell Carcinoma

(2017) Xiaosai Yao et al.   Cancer Discovery

The Transcription Factor ZNF395 Is Required for the Maximal Hypoxic Induction of Proinflammatory Cytokines in U87-MG Cells

(2015) Christine Herwartz et al.   MEDIATORS OF INFLAMMATION

Genetic Evidence of a Precisely Tuned Dysregulation in the Hypoxia Signaling Pathway during Oncogenesis

(2014) S. Couve et al.   CANCER RESEARCH

Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins

(2014) Hani Goodarzi et al.   NATURE

MiR-525-3p Enhances the Migration and Invasion of Liver Cancer Cells by Downregulating ZNF395

(2014) Fei Pang et al.   PLoS One

Global Gene Expression Profiling in Three Tumor Cell Lines Subjected to Experimental Cycling and Chronic Hypoxia

(2014) Magdalena Olbryt et al.   PLoS One

The Hypoxia-Inducible Transcription Factor ZNF395 Is Controlled by IĸB Kinase-Signaling and Activates Genes Involved in the Innate Immune Response and Cancer

(2013) Darko Jordanovski et al.   PLoS One

Association of Elevated HIF-2α Levels with Low Beclin 1 Expression and Poor Prognosis in Patients with Chondrosarcoma

(2011) Changbao Chen et al.   ANNALS OF SURGICAL ONCOLOGY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Reduced Expression of von Hippel-Lindau Protein Correlates with Decreased Apoptosis and High Chondrosarcoma Grade

(2011) Changbao Chen et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Increased levels of hypoxia-inducible factor-1α are associated with Bcl-xL expression, tumor apoptosis, and clinical outcome in chondrosarcoma

(2010) Changbao Chen et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients

(2010) Paolo Fardin et al.   Molecular Cancer

Scythe/BAT3 regulates apoptotic cell death induced by papillomavirus binding factor in human osteosarcoma

(2009) Tomohide Tsukahara et al.   CANCER SCIENCE

Modulation of Angiogenic and Inflammatory Response in Glioblastoma by Hypoxia

(2009) Anastasia Murat et al.   PLoS One

Prognostic impact and immunogenicity of a novel osteosarcoma antigen, papillomavirus binding factor, in patients with osteosarcoma

(2008) Tomohide Tsukahara et al.   CANCER SCIENCE